CDKN2A overexpression
|
Soft Tissue Sarcoma
|
CDKN2A overexpression
|
Soft Tissue Sarcoma
|
olaparib + trabectedin Sensitive: C3 – Early Trials
|
olaparib + trabectedin Sensitive: C3 – Early Trials
|
CDKN2A overexpression
|
Ovarian Cancer
|
CDKN2A overexpression
|
Ovarian Cancer
|
palbociclib Sensitive: D – Preclinical
|
palbociclib Sensitive: D – Preclinical
|
CDKN2A overexpression
|
Mantle Cell Lymphoma
|
CDKN2A overexpression
|
Mantle Cell Lymphoma
|
venetoclax Sensitive: D – Preclinical
|
venetoclax Sensitive: D – Preclinical
|